Pressure Infusion Bags Market to Reach USD 494.5 Million by 2029 with a 6.5% of CAGR, Growing at a Strong Pace

Pressure Infusion Bags Market
Pressure Infusion Bags Market

The global Pressure Infusion Bags Market, valued at USD 300.0 million in 2021, is projected to grow significantly, reaching USD 494.5 million by 2029, according to a recent market survey by Future Market Insights (FMI). This growth reflects the increasing adoption of pressure infusion bags in emergency and surgical care settings, driven by advancements in healthcare practices and growing patient care demands.

Pressure infusion bags are essential medical devices used to rapidly infuse fluids into patients, especially in critical situations such as trauma, shock, and surgery. Their ability to enhance fluid delivery under controlled pressure is vital in stabilizing patients during emergencies and complex procedures. The market’s expansion is driven by the rising incidence of trauma cases, surgical procedures, and the growing demand for efficient and reliable medical equipment in intensive care units (ICUs).

Technological improvements in pressure infusion bags, including more durable materials, ease of use, and better pressure regulation, are also contributing to market growth. Additionally, increasing healthcare investments, particularly in emerging economies, are further boosting demand for these devices.

North America is expected to dominate the market due to advanced healthcare infrastructure and high demand for critical care equipment. However, the Asia-Pacific region is anticipated to witness the fastest growth, fueled by healthcare modernization efforts, improving patient care services, and rising medical device adoption in hospitals and clinics.

Key Takeaways:

  • The global pressure infusion bags market is projected to grow from USD 300.0 million in 2021 to USD 494.5 million by 2029.
  • Growth is driven by increasing adoption in emergency care, trauma, and surgical procedures.
  • Advancements in material durability and pressure regulation technology are enhancing product performance.
  • North America leads the market, while Asia-Pacific is expected to grow at the fastest pace due to rising healthcare investments and demand for medical devices.

The measurement of continuous beat-to-beat blood pressure by a pressure infuser coupled with other monitoring devices is an invasive method that is widely used by physicians.

Major fluids in rapid infusion include blood, blood products, blood expanders and intravenous solution. Certain factors that are driving the pressure infusion bags market growth include rapid infusion of blood and drugs that are necessary for patients suffering from trauma-induced haemorrhage, postpartum haemorrhage, and cardiac surgery.

Competitive Landscape

Companies in the pressure infusion bags market are pursuing new product innovation and launches, regulatory approvals, and company expansions as key strategies. The global pressure infusion bags market is exceptionally fragmented with the presence of several players.

The players are heavily investing in research to develop a novel product as an effective strategy to provide products to end consumers with an effective minimum price. The key players are highly focused on strengthening their product portfolio and expanding their sales footprint across the globe by entering into strategic agreements with the local distributors which are essential to enhance distribution efficiency.

This is majorly practiced by manufacturers to increase their market share. Thereby, focusing on the development of novel and cost-effective pressure infusion bags to eradicate unmet needs. Along with this, the players are establishing distribution agreements to increase geographic reach.

For instance

  • In April 2021, Gland Pharma Ltd. received approval from the United States of America Food and Drug Administration (US FDA) for a generic Foscarnet Sodium Injection, 6000 mg/250 mL (24 mg/mL) Single-Dose bag for infusion. With this approval, Gland Pharma secured the first generic offering status in Single-Dose Bag for infusion.
  • In February 2017, ICU Medical, Inc. acquired Hospira Infusion Systems (HIS) business from Pfizer, Inc. This acquisition helped the company improve its infusion therapy segment.

Key Companies Profiled

Vyaire Medical Inc.; Spengler SAS; Merit Medical Systems, Inc.; Statcorp Medical; Armstrong Medical; Salter Labs; Sarstedt AG & Co. KG; Smiths Medical; SunMed; Tapmedic LLC; VBM Medizintechnik GmbH; Rudolf Riester GmbH; Friedrich Bosch GmbH & Co. KG; Accoson Ltd.; ERKA. Kallmeyer Medizintechnik GmbH & Co. KG.

Access the Full Report

Pressure Infusion Bags Market by Category

By Product:

  • Reusable Pressure Infusion Bags
  • Disposable Pressure Infusion Bags

By Material:

  • Nylon
  • Polyurethane
  • Latex
  • Others

By Capacity:

  • 500cc
  • 1000cc
  • 3000cc
  • Above 3000cc

By Application:

  • Blood & Drug Infusion
  • Invasive Pressure Monitoring Procedure

By Indications:

  • Trauma-Induced Haemorrhage
  • Obstetric Haemorrhage
  • Coagulopathy during cardiopulmonary bypass

By End User:

  • Hospitals
  • Out-patient facilities
  • Clinics
  • Long-term care centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these